A visual representation of ovarian cancer. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

INOVIQ (ASX:IIQ) has announced encouraging blood test identification results for ovarian cancer.

On completion of its “analytical validation study”, the biotechnology company said the tests had “correctly” identified 85% of all samples tested.

This comprised 76% of cancer-positive samples compared to 94% cancer free samples.

Inoviq did not refer to previous test results for comparative purposes, but is presenting its blood test solution for cancer tests as a simple, accurate and affordable combination immonouassay.

It was developed using a CA125 monoclonal antibody used by leading diagnostic companies, combined with Inoviq’s SubB2M detection reagent.

Inoviq said: “The addition of SubB2M ensures that the test only detects CA125 that is produced by cancer cells, resulting in improved specificity for cancer and potentially a reduced number of false positive test results.”

The Melbourne headquartered company is also striving to develop tests to detect breast cancer and includes a team of 19 based researchers in the United States with 11 of those holding 8 PhDs.

Research, development and clinical testing takes place at the company’s cGMP approved production site.

Inoviq was down 3% in early trade at 62 cents.

IIQ by the numbers
More From The Market Online
The Market Online Video

Market Update: ASX accelerates ahead of future forecasts

The ASX200 delivered a sweet surprise this morning, surging 1.7 per cent to deliver growth far in excess of future’s predictions.

Encounter pulls a rabbit out of the hat chasing copper at Sandover

Encounter Resources Ltd has found high grade copper through drilling at its Sandover project in the…

iTech reaches graphite concentrate of 94% from Lacroma project in SA

iTech Minerals Ltd has produced a total graphite carbon (TGC) concentrate of 94 percent from its…
The Market Online Video

Market Close: Green light launches ASX lift off as US inflation ebbs

The ASX200 closed nearly 1.6% up. Every sector – aside from energy – ended in the green.